Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes

Diabetes Metab Rev. 1986;2(1-2):125-61. doi: 10.1002/dmr.5610020108.
No abstract available

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • Animals
  • Animals, Newborn
  • Arginine / pharmacology
  • Blood Glucose / metabolism
  • Cyclic AMP / physiology
  • Diabetes Mellitus, Experimental / pathology*
  • Diabetes Mellitus, Experimental / physiopathology
  • Diabetes Mellitus, Type 1 / pathology*
  • Diabetes Mellitus, Type 1 / physiopathology
  • Diabetes Mellitus, Type 2 / pathology*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Drug Synergism
  • Glucagon / metabolism
  • Glucose / administration & dosage
  • Glucose / metabolism
  • Glucose / pharmacology
  • Glucose Tolerance Test
  • Histocytochemistry
  • Humans
  • Immunologic Techniques
  • In Vitro Techniques
  • Insulin / metabolism
  • Insulin Resistance
  • Insulin Secretion
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / pathology*
  • Islets of Langerhans / physiopathology
  • Pancreatectomy
  • Rats
  • Rats, Inbred Strains

Substances

  • Blood Glucose
  • Insulin
  • Glucagon
  • Arginine
  • Cyclic AMP
  • Glucose
  • 1-Methyl-3-isobutylxanthine